申请人:Pfizer Inc.
                            
                            
                                公开号:US20140057919A1
                            
                            
                                公开(公告)日:2014-02-27
                            
                            The present invention is directed to a new class of hydroxamic acid derivatives, their use as LpxC inhibitors and, more specifically, their use to treat bacterial infections.
                            本发明涉及一种新的羟
肟酸衍
生物类,它们作为LpxC
抑制剂的用途,更具体地说,它们用于治疗细菌感染。